Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance

Menopause

Volumn 16, Issue 5, 2009, Pages 971-977

  Urushihara, Hisashi ^a,b   Kikuchi, Nobutaka ^a   Yamada, Mayumi ^a   Yoshiki, Fumito ^a   Miyauchi, Akimitsu ^a  

^a ELI LILLY AND COMPANY   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Japanese women; Postmarketing surveillance; Postmenopausal osteoporosis; Raloxifene; Stroke risk

Indexed keywords

RALOXIFENE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; DRUG SAFETY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; OSTEOPOROSIS; POSTMARKETING SURVEILLANCE; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CAUSE OF DEATH; COMORBIDITY; EPIDEMIOLOGIC STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PRODUCT SURVEILLANCE, POSTMARKETING; RALOXIFENE; RISK ASSESSMENT; RISK FACTORS; SAFETY; STROKE; TREATMENT OUTCOME;

EID: 73349089010     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181a15622     Document Type: Article

References (19)

1. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk, in postmenopausal, women with, osteoporosis treated with raloxifene-results from, a 3-year randomized clinical trial. JAMA 1999; 282:637-645. (Pubitemid 29384151)
2. Nakamura T, Liu JL, Morii. H, et al. Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis. J Bone Miner Metab 2006;24:414-418. (Pubitemid 44306179)
3. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 1999;281:2189-2197.
4. Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes-The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295:2727-2741. (Pubitemid 43920726)
5. Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125-137. (Pubitemid 44050394)
6. Martino S, Cauley J, Barrett-Connor E, et al. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in. a randomized trial of raloxifene. J Natl Cancer Inst 2004;96:1751-1761. (Pubitemid 39654569)
7. World Health Organization. WHO Statistical Information System: agestandardized mortality rate for cardiovascular diseases (per 100 000 population). 2002. Available at: http://www.who.int/whosis/indicators/ compendium/2008/1mst. Accessed October 1, 2008.
8. Nagura J, Suzuki K, Hayashi M, et al. Stroke subtypes and lesion sites in Akita, Japan. J Stroke Cerebrovasc Dis 2005;14:1-7. (Pubitemid 40093708)
9. Kita Y. Stroke types and risk factors: study on stroke types by gender and age on regional incidence registry [in Japanese]. Domyaku Koka Yobo 2007;5:14-21.
10. Kimura Y, Takishita S, Muratani H, et al. Demographic study of firstever stroke and acute myocardial infarction in Okinawa, Japan. Intern Med 1998;37:736-745. (Pubitemid 128519360)
11. Sato T. Confounding and effect modification in epidemiologic studies [in Japanese]. Proc Inst Stat Math 1994;42:83-101.
12. Sato T. Epidemiology. In: Miyahara H, Tango T, eds. Medical Statistics Handbook [in Japanese]. Tokyo: Asakura Pubishing Co., Ltd., 1995.
13. Ministry of Health, Labour and Welfare. MHLW Statistical Database: National Statistics on Patient Survey in 2005. Available at: http://wwwdbtk.mhlw.go.jp/toukei/index.html [in Japanese]. Accessed August 21, 2008.
14. Mosca L, Grady D, Barrett-Connor E, et al. Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke 2009;40:147-155.
15. Jørgensen L, Engstad T, Jacobsen BK, Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women. Stroke 2001;32:47-51. (Pubitemid 32063822)
16. Suzuki K, Stroke types and risk factors: trends in stroke subtypes on whole region stroke registry in Akita Prefecture [in Japanese]. Domyaku Koka Yobo 2007;5:22-26.
17. Cox DA, Barrett-Connor E, Song J, Mitlak B, Grady D. S-4. Raloxifene and cerebrovascular events in postmenopausal women stratified by Framingham stroke risk. In Abstracts: 19th Annual Meeting of The North American Menopause Society; September 24-27, 2008; Orlando, FL. Menopause 2008;15:1197-1232.
18. Prandoni P, Bilora F, Marchiori. A, et al. An association, between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-1441.
19. Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni. P. Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007;370:1773-1779. (Pubitemid 350137491)